Akero Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
21.03.23
/
50%
€34.60
Target price
21.03.24
€53.84
Performance (%)
-31.21%
End price
22.03.24
€23.80
Summary
This prediction ended on 22.03.24 with a price of €23.80. The BUY prediction by Canaccord_Genuity_Gr for Akero Therapeutics Inc performed very badly with a performance of -31.21%. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | 0.278% | 0.278% | 70.552% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target raised by analysts at Canaccord Genuity Group Inc. from $50.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten